Increased angiogenesis in primary myelofibrosis: latent transforming growth factor-β as a possible angiogenic factor

Increased angiogenesis in primary myelofibrosis: latent transforming growth factor-β as a possible angiogenic factor

Autor Ponce, Cesar Cilento Google Scholar
Chauffaille, Maria de Lourdes Lopes Ferrari Autor UNIFESP Google Scholar
Ihara, Silvia Saiuli Miki Autor UNIFESP Google Scholar
Silva, Maria Regina Regis Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Objective: The aim of this work was to demonstrate a possible relationship between anti-latency-associated peptide human latent transforming growth factor beta 1 (latent TGF-β1) expression in megakaryocytes and microvascular density in bone marrow biopsies from patients with essential thrombocythemia and primary myelofibrosis. Methods: Microvascular density was evaluated by immunohistochemical analysis and the expression of latent TGF-β1 in samples (100 megakaryocytes per bone marrow sample) from 18 essential thrombocythemia and 38 primary myelofibrosis (19 prefibrotic and 19 fibrotic) patients. Six bone marrow donor biopsies were used as controls. Fibrosis in the bone marrow biopsies was evaluated according to the European Consensus. Results: The average fibrosis grade differed between essential thrombocythemia and primary myelofibrosis groups when compared to the control group. Latent TGF-β1 expression differed significantly between the fibrotic primary myelofibrosis (PMF) group and the control group (p-value < 0.01). A high degree of neo-angiogenesis (demonstrated by analysis of CD34 expression) was detected in patients with myelofibrosis. There were correlations between latent TGF-β1 expression and microvascular density (r = 0.45; p-value < 0.0009) and between degree of microvascular density and fibrosis grade (r = 0.80; p-value < 0.0001). Remarkable differences for neo-angiogenesis were not observed between patients with essential thrombocythemia and controls. Conclusion: Angiogenesis participates in the pathogenesis of primary myelofibrosis, in both the prefibrotic and fibrotic stages, while latent TGF-β is differentially expressed only in the prefibrotic stage.
Assunto Angiogenesis inducing agents
Primary myelofibrosis
Transforming growth factor beta
Antigens, CD34
Fibrosis
Idioma Inglês
Data 2014-10-01
Publicado em Revista Brasileira de Hematologia e Hemoterapia. Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, v. 36, n. 5, p. 322-328, 2014.
ISSN 1516-8484 (Sherpa/Romeo)
Editor Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
Extensão 322-328
Fonte http://dx.doi.org/10.1016/j.bjhh.2014.07.010
Direito de acesso Acesso aberto Open Access
Tipo Artigo
SciELO S1516-84842014000500322 (estatísticas na SciELO)
URI http://repositorio.unifesp.br/handle/11600/8637

Mostrar registro completo




Arquivos deste item

Nome: S1516-84842014000500322.pdf
Tamanho: 1.484Mb
Formato: PDF
Descrição:
Visualizar/Abrir

Este item aparece na(s) seguinte(s) coleção(s)